Axillary lymph-node metabolic activity assessment on ¹⁸F-FDG-PET/CT in rheumatoid arthritis patients treated with biologic therapies

References

• Feldmann M, Brennan FM, Maini RN. Rheumatoid arthritis. Cell 1996;85:307–10.
   PubMed Web of Science ®Google Scholar
• Firestein GS, McInnes IB. Immunopathogenesis of rheumatoid arthritis. Immunity 2017;46:183–96.
   PubMed Web of Science ®Google Scholar
• Proulx ST, Kwok E, You Z, Beck CA, Shealy DJ, Ritchlin CT, et al. MRI and quantification of draining lymph node function in inflammatory arthritis. Ann N Y Acad Sci 2007;1117:106–23.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Guo R, Wood R, Boyce BF, Liang Q, Wang YJ, et al. Vascular endothelial growth factor c attenuates joint damage in chronic inflammatory arthritis by accelerating local lymphatic drainage in mice. Arthritis Rheum 2011;63:2318–28.
   PubMed Web of Science ®Google Scholar
• Li J, Ju Y, Bouta EM, Xing L, Wood RW, Kuzin I, et al. Efficacy of B cell depletion therapy for murine joint arthritis flare is associated with increased lymphatic flow. Arthritis Rheum 2013;65:130–8.
   PubMed Web of Science ®Google Scholar
• Calguneri M, Ozturk MA, Ozbalkan Z, Akdogan A, Ureten K, Kiraz S, et al. Frequency of lymphadenopathy in rheumatoid arthritis and systemic lupus erythematosus. J Int Med Res 2003;31:345–9.
   PubMed Web of Science ®Google Scholar
• Kubota K, Ito K, Morooka M, Mitsumoto T, Kurihara K, Yamashita H, et al. Whole-body FDG-PET/CT on rheumatoid arthritis of large joints. Ann Nucl Med 2009;23:783–91.
   PubMed Web of Science ®Google Scholar
• Manzo A, Caporali R, Vitolo B, Alessi S, Benaglio F, Todoerti M, et al. Subclinical remodelling of draining lymph node structure in early and established rheumatoid arthritis assessed by power Doppler ultrasonography. Rheumatology (Oxford) 2011;50:1395–400.
   PubMed Web of Science ®Google Scholar
• Rahimi H, Dieudonne G, Kheyfits V, Bouta EM, Wood RW, Barrett R, et al. Relationship between lymph node volume and pain following certolizumab therapy for rheumatoid arthritis flare: a pilot study. Clin Med Insights Arthritis Musculoskelet Disord 2016;9:203–8.
   PubMed Web of Science ®Google Scholar
• Vijayant V, Sarma M, Aurangabadkar H, Bichile L, Basu S. Potential of (18)F-FDG-PET as a valuable adjunct to clinical and response assessment in rheumatoid arthritis and seronegative spondyloarthropathies. World J Radiol 2012;4:462–8.
   PubMedGoogle Scholar
• Beckers C, Ribbens C, Andre B, Marcelis S, Kaye O, Mathy L, et al. Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET. J Nucl Med 2004;45:956–64.
   PubMed Web of Science ®Google Scholar
• Goerres GW, Forster A, Uebelhart D, Seifert B, Treyer V, Michel B, et al. F-18 FDG whole-body PET for the assessment of disease activity in patients with rheumatoid arthritis. Clin Nucl Med 2006;31:386–90.
   PubMed Web of Science ®Google Scholar
• Okamura K, Yonemoto Y, Arisaka Y, Takeuchi K, Kobayashi T, Oriuchi N, et al. The assessment of biologic treatment in patients with rheumatoid arthritis using FDG-PET/CT. Rheumatology (Oxford) 2012;51:1484–91.
   PubMed Web of Science ®Google Scholar
• Okamura K, Yonemoto Y, Okura C, Higuchi T, Tsushima Y, Takagishi K. Evaluation of tocilizumab therapy in patients with rheumatoid arthritis based on FDG-PET/CT. BMC Musculoskelet Disord 2014;15:393.
   PubMed Web of Science ®Google Scholar
• Yonemoto Y, Okamura K, Takeuchi K, Kaneko T, Kobayashi T, Okura C, et al. [18F]Fluorodeoxyglucose uptake as a predictor of large joint destruction in patients with rheumatoid arthritis. Rheumatol Int 2016;36:109–15.
   PubMed Web of Science ®Google Scholar
• Yonemoto Y, Okamura K, Kobayashi T, Kaneko T, Okura C, Suto T, et al. Predictive factors related to shoulder joint destruction in rheumatoid arthritis patients treated with biologics: a prospective study. Mod Rheumatol 2017;27:587–92.
   PubMed Web of Science ®Google Scholar
• Yonemoto Y, Okamura K, Kaneko T, Okura C, Kobayashi T, Suto T, et al. Effect of total knee arthroplasty on other joints in patients with rheumatoid arthritis evaluated by 18-FDG-PET. Int J Rheum Dis 2017;20:702–7.
   PubMed Web of Science ®Google Scholar
• Suto T, Okamura K, Yonemoto Y, Okura C, Tsushima Y, Takagishi K. Prediction of large joint destruction in patients with rheumatoid arthritis using 18F-FDG PET/CT and disease activity score. Medicine (Baltimore) 2016;95:e2841.
   PubMed Web of Science ®Google Scholar
• Suto T, Yonemoto Y, Okamura K, Okura C, Kaneko T, Kobayashi T, et al. Predictive factors associated with the progression of large-joint destruction in patients with rheumatoid arthritis after biologic therapy: a post-hoc analysis using FDG-PET/CT and the ARASHI (Assessment of Rheumatoid Arthritis by Scoring of large-joint destruction and Healing in radiographic Imaging) scoring method. Mod Rheumatol 2017;27:820–7.
   PubMed Web of Science ®Google Scholar
• Bhattarai A, Nakajima T, Sapkota S, Arisaka Y, Tokue A, Yonemoto Y, et al. Diagnostic value of 18F-fluorodeoxyglucose uptake parameters to differentiate rheumatoid arthritis from other types of arthritis. Medicine (Baltimore) 2017;96:e7130.
   PubMed Web of Science ®Google Scholar
• Husby JA, Reitan BC, Biermann M, Trovik J, Bjorge L, Magnussen IJ, et al. Metabolic tumor volume on 18F-FDG PET/CT improves preoperative identification of high-risk endometrial carcinoma patients. J Nucl Med 2015;56:1191–8.
   PubMed Web of Science ®Google Scholar
• Saboury B, Salavati A, Brothers A, Basu S, Kwee TC, Lam MG, et al. FDG PET/CT in Crohn’s disease: correlation of quantitative FDG PET/CT parameters with clinical and endoscopic surrogate markers of disease activity. Eur J Nucl Med Mol Imaging 2014;41:605–14.
   PubMed Web of Science ®Google Scholar
• Bugatti S, Vitolo B, Caporali R, Montecucco C, Manzo A. B cells in rheumatoid arthritis: from pathogenic players to disease biomarkers. BioMed Res Int 2014;2014:14.
   Web of Science ®Google Scholar
• Kim H-J, Berek C. B cells in rheumatoid arthritis. Arthritis Res Ther 2000;2:126.
   Web of Science ®Google Scholar
• Matsui T, Nakata N, Nagai S, Nakatani A, Takahashi M, Momose T, et al. Inflammatory cytokines and hypoxia contribute to 18F-FDG uptake by cells involved in pannus formation in rheumatoid arthritis. J Nucl Med 2009;50:920–6.
   PubMed Web of Science ®Google Scholar
• Fransen J, van Riel PLCM. The disease activity score and the EULAR response criteria. Rheum Dis Clin North Am 2009;35:745–57.
   PubMed Web of Science ®Google Scholar
• Seldin DW, Habib I, Soudry G. Axillary lymph node visualization on F-18 FDG PET body scans in patients with rheumatoid arthritis. Clin Nucl Med 2007;32:524–6.
   PubMed Web of Science ®Google Scholar
• dos Anjos DA, do Vale GF, Campos CM, do Prado LF, Sobrinho AB, da Cunha AL, et al. Extra-articular inflammatory sites detected by F-18 FDG PET/CT in a patient with rheumatoid arthritis. Clin Nucl Med 2010;35:540–1.
   PubMed Web of Science ®Google Scholar
• Basu S, Shejul Y. Regional lymph node hypermetabolism corresponding to the involved joints on FDG-PET in newly diagnosed patients of rheumatoid arthritis: observation and illustration in symmetrical and asymmetric joint involvement. Rheumatol Int 2014;34:413–15.
   PubMed Web of Science ®Google Scholar
• Proulx ST, Kwok E, You Z, Papuga MO, Beck CA, Shealy DJ, et al. Longitudinal assessment of synovial, lymph node, and bone volumes in inflammatory arthritis in mice by in vivo magnetic resonance imaging and microfocal computed tomography. Arthritis Rheum 2007;56:4024–37.
   PubMed Web of Science ®Google Scholar
• Manzo A, Benaglio F, Vitolo B, Bortolotto C, Zibera F, Todoerti M, et al. Power Doppler ultrasonographic assessment of the joint-draining lymph node complex in rheumatoid arthritis: a prospective, proof-of-concept study on treatment with tumor necrosis factor inhibitors. Arthritis Res Ther 2016;18:242.
   PubMed Web of Science ®Google Scholar
• Kondratowicz GM, Symmons DP, Bacon PA, Mageed RA, Jones EL. Rheumatoid lymphadenopathy: a morphological and immunohistochemical study. J Clin Pathol 1990;43:106–13.
   PubMed Web of Science ®Google Scholar
• Nosanchuk JS, Schintzier B. Follicular hyperplasia in lymph nodes from patients with rheumatoid arthritis. A clinicopathologic study. Cancer 1969;24:343–54.
   Web of Science ®Google Scholar
• Willkens RF, Roth GF, Husby G, Williams RC. Immunocytological studies of lymph nodes in rheumatoid arthritis and malignant lymphoma. Ann Rheum Dis 1980;39:147–51.
   PubMed Web of Science ®Google Scholar
• van Baarsen LG, de Hair MJ, Ramwadhdoebe TH, Zijlstra IJ, Maas M, Gerlag DM, et al. The cellular composition of lymph nodes in the earliest phase of inflammatory arthritis. Ann Rheum Dis 2013;72:1420–4.
   PubMed Web of Science ®Google Scholar
• Li J, Kuzin I, Moshkani S, Proulx ST, Xing L, Skrombolas D, et al. Expanded CD23(+)/CD21(hi) B cells in inflamed lymph nodes are associated with the onset of inflammatory-erosive arthritis in TNF-transgenic mice and are targets of anti-CD20 therapy. J Immunol 2010;184:6142–50.
   PubMed Web of Science ®Google Scholar
• Shozushima M, Tsutsumi R, Terasaki K, Sato S, Nakamura R, Sakamaki K. Augmentation effects of lymphocyte activation by antigen-presenting macrophages on FDG uptake. Ann Nucl Med 2003;17:555–60.
   PubMed Web of Science ®Google Scholar